Please do not adjust margins
Physical Chemistry Chemical Physics
Page 9 of 11
DOI: 10.1039/C8CP02433B
Journal Name
ARTICLE
relationship between enhanced intensity and cTnT gratitude towards Director, CSIR-NEIST, Jorhat for his interest
concentration can be expressed by the equation (F- in this work.
F0)=21.538[cTnT]+58.223. The LoD and LoQ value for the
detection of cTnT in serum was found as 0.99 and 3.01 ng mL-1.
Notes
These values are slightly higher than the values calculated for
cTnT detection in buffer. Such type of deviation may occur by
ORCID
non-specific absorption originated from the other
Satyabrat Gogoi: 0000-0002-8860-5615
biomolecules present in blood serum. Thus, shows a minor
Raju Khan: 0000-0002- 3007-0232
influence of the intefrents on the sensing performance of anti-
cTnT-f-CD/MoS2 sensing probe for detection of cardiac cTnT in
a replica of real sample. Generally, blood serum contains other
proteins and bio-entities abundantly at
a much higher
References
concentrations than troponin. Considering high abundance of
these bio-components in serum, the recovery percentage of
cTnT by the current method is promising. Thus, obtained
results are good enough to highlight the analytical
performance of anti-cTnT-f-CDs/MoS2 in the detection of cTnT.
1
G.W. Reed, J.E. Rossi, C.P. Cannon, J.-Lancet 2017,
389(10065), 197-210.
2
T.A. Gaziano, J.M. Gaziano, in Myocardial Infarction: A
Companion to Braunwald's Heart Disease E-Book, D.A.
Morrow, Eds.; Elsevier, St Louis, 2016, Chapter 2, pp 11−21.
R. Bruyninckx, B. Aertgeerts, P. Bruyninckx, F. Buntinx, Br. J.
Gen. Pract. 2008, 58(547), e1-e8.
M. Rubini Gimenez, R. Twerenbold, T. Reichlin, K. Wildi, P.
Haaf, M. Schaefer, M. Mueller, Eur. Heart J. 2014, 35(34),
2303-2311.
3
4
Conclusions
Thus, we have reported NIR responded carbon dots/MoS2
sensing platform for selective cardiac troponin T detection.
The optical study demonstrated an effective dynamic energy
transfer between zero dimensional carbon dots to two
dimensional nanosheets of MoS2. Both the static and dynamic
fluorescence measurements are implicative for a FRET based
sensing platform using carbon dot/MoS2 nano-couple. The
5
6
T. Jernberg, P. Hasvold, M. Henriksson, H. Hjelm, M.
Thuresson, M. Janzon, Eur. Heart J. 2015, 36(19), 1163-1170.
L.B. Daniels, P. Clopton, O.A. Sanchez, H. Bahrami, J.A. Lima,
R.P. Tracy, D. Siscovick, A.G. Bertoni, P. Greenland, M.
Cushman, A.S. Maisel, M.H. Criqui, Am. Heart J. 2015, 170(6),
1170-1183.
N. Bansal, A.H. Anderson, W. Yang, R.H. Christenson, R. Deo,
D.L. Dries, A.S. Go, J. He, J.W. Kusek, J.P. Lash, D. Raj, S.
Rosas, M. Wolf, X. Zhang, M.G. Shlipak, H.I. Feldman, J. Am.
Soc. Nephrol. 2014, 26, 1-11.
7
sensor responds linearly to the cardiac troponin
T
concentrations in the range of 0.1-50 ng mL-1, with the
experimental detection limit of 0.12 ng mL-1. The sensor shows
minor response to other proteins and bio-entities abundantly
present in the blood serum at a higher concentrations than
troponin. Therefore, current method holds high potentiality to
be used in real sample analysis. However, upgrading of the
sensing performance is implicative prior to clinical use,
especially to improve the sensitivity and lower limit of
detection in biological fluids (including undiluted serum or
whole blood). In this regard, material modification through
surface variation of carbon dots may provide a unique route to
enhance fluorescence property of the probe as well as to
achieve better sensing performance. In short we can conclude
that current work might open up new possibilities in diagnosis
of cardiac troponins.
8
9
X. Han, S. Li, Z. Peng, A.M. Othman, R. Leblanc, ACS Sens.
2016, 1(2), 106-114.
H. Jo, H. Gu, W. Jeon, H. Youn, J. Her, S. K. Kim, J. Lee, J.H.
Shin, C. Ban, Anal. Chem. 2015, 87(19), 9869-9875.
10 R. Fernández-Jiménez, J. Silva, S. Martínez-Martínez, M.D.
López-Maderuelo, M. Nuno-Ayala, J.M. García-Ruiz, A.
García-Álvarez, L. Fernández-Friera, T. Gonzalo Pizarro, J.
García-Prieto, D. Sanz-Rosa, G. López-Martin, A. Fernández-
Ortiz, C. Macaya, V. Fuster, J.M. Redondo, B. Ibanez, J. Am.
Heart Assoc. 2015, 4(1), e001218.
11 R.D. Munje, M. Jacobs, S. Muthukumar, B. Quadri, N.R.
Shanmugam, S. Prasad, Anal. Methods 2015, 7(24), 10136-
10144.
12 H.A. Katus, A. Remppis, F.J. Neumann, T. Scheffold, K.W.
Diederich, G. Vinar, A. Noe, G. Matern, W. Kuebler,
Circulation 1991, 83(3), 902-912.
13 P.O. Collinson, M.P. van Dieijen-Visser, K. Pulkki, A.
Hammerer-Lercher, J. Suvisaari, J. Ravkilde, A. Stavljenic-
Rukavina, H. Baum, P. Laitinen, Clin. Chem. (Washington, DC,
U. S.) 2012, 58(1), 305-306.
Conflicts of interest
14 K.F. Buechler, (2000). U.S. Patent No. 6,019,944.
Washington, DC: U.S. Patent and Trademark Office.
15 K. Aslan, T.A. Grell, Clin. Chem. (Washington, DC, U. S.) 2011,
57(5), 746-752.
There are no conflicts to declare.
16 Y. Qiao, H. Tang, G.R. Munske, P. Dutta, C.F. Ivory, W.J. Dong,
J. Fluoresc. 2011, 21(6), 2101.
Acknowledgements
17 P. Kar, A. Pandey, J.J. Greer, K. Shankar, Lab Chip 2012, 12(4),
821-828.
18 D. Bhatnagar, V. Kumar, A. Kumar, I. Kaur, Biosens.
Bioelectron. 2016, 79, 495-499.
19 J. Zhang, S. Kruss, A.J. Hilmer, S. Shimizu, Z. Schmois, F. De La
Cruz, P.W. Barone, N.F. Reuel, D.A. Heller, M.S. Strano, Adv.
Healthcare Mater. 2014, 3(3), 412-423.
Science & Engineering Research Board (SERB), Department of
Science & Technology (DST), Government of India (Grant no-
PDF/2016/003142) for financial support. CSIR-Advanced
Analytical Facility for NE (CAAF-NE), CSIR-NEIST, Jorhat for the
SEM/EDS and TEM analysis. The authors also extend their
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 9
Please do not adjust margins